Research opportunities for the primordial prevention of rheumatic fever and rheumatic heart disease—streptococcal vaccine development: a national heart, lung and blood institute workshop report

• Madeleine W Cunningham,
• Alma Fulurija,
• Natalia Korotkova,
• Mary Y. Masterson,
• Geetha P. Bansal,
• Michael G. Baker,
• Jeffrey W. Cannon,
• Jonathan R. Carapetis,
• Andrew C. Steer

Affiliations

Madeleine W Cunningham

The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

Alma Fulurija

Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia

Natalia Korotkova

Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky, Lexington, Kentucky, USA

Mary Y. Masterson

Center for Translation Research and Implementation Science (CTRIS), National Heart Lung and Blood Institute, Bethesda, Maryland, USA

Geetha P. Bansal

John E Fogarty International Center, Bethesda, Maryland, USA

Michael G. Baker

Department of Public Health, University of Otago Wellington, Wellington, New Zealand

Jeffrey W. Cannon

Centre for Child Health Research, The University of Western Australia, Perth, Western Australia, Australia

Jonathan R. Carapetis

Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia

Andrew C. Steer

Infection, Immunity and Global Health, Murdoch Children`s Research Institute, Parkville, Victoria, Australia